D-0882-2022 Class I
FDA drug recall D-0882-2022 was initiated by Cardinal Health Inc. on April 5, 2022 and is designated Class I. Reason for recall: TEMPERATURE ABUSE: Products were exposed to temperatures outside of the products labeled storage conditions due to inclement weather. Affected quantity: 1 box.
Recall Details
- Product Type
- Drugs
- Report Date
- May 25, 2022
- Initiation Date
- April 5, 2022
- Termination Date
- N/A
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 1 box
Product Description
Humalog KwikPen, Insulin lispro injection, U-100, 100 units per mL, 5x3 mL Prefilled Pens per box, Marketed by Lilly USA, LLC, Indianapolis, IN 46285, Box NDC 0002-8799-59, Pen NDC 002-7516-59
Reason for Recall
TEMPERATURE ABUSE: Products were exposed to temperatures outside of the products labeled storage conditions due to inclement weather.
Distribution Pattern
NM only
Code Information
Unknown